肉毒毒素200年的时间表:从生物毒素到奇药
Journal of drugs in dermatology : JDD
|January 11, 2024
概括
最初与食源性疾病相关的肉毒毒素,在200多年中发展成为一种重要的医疗治疗方法. 今天,六种商业化产品服务于各种专业,展示了从毒药到奇药的旅程.
科学领域:
- 医学史 医学史 医学史
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
背景情况:
- 肉毒毒素的起源可以追溯到18世纪欧洲和美国的食物传播肉毒症爆发.
- 两个多世纪的研究已经将这种毒素转化为重要的医疗创新.
- 这篇文章探讨了肉毒毒素的历史轨迹和科学演变.
研究的目的:
- 为了记录玻尿素毒素的历史发展.
- 突出其科学旅程中的关键里程碑和个人.
- 审查它从毒药转变为治疗剂的过程.
主要方法:
- 科学文献和医疗记录的历史审查.
- 追踪肉毒毒素发现和应用的时间表.
- 记录肉毒素产品的商业化和临床适用情况.
主要成果:
- 肉毒毒素的历史跨越200多年,起源于食物传播的疫情.
- 目前在北美商业化有六种肉毒毒素产品.
- 适用于眼科,神经病学,泌尿病学,皮肤病学,整形外科和耳鼻喉学.
结论:
- 肉毒毒素是从危险的毒素转变为多功能的治疗药物的例子.
- 它丰富的历史强调了重要的科学研究和医疗创新.
- 目前广泛的应用突显了它在现代医学中的持久重要性.
更多相关视频
12:25Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
Published on: March 3, 2014
16.0K
10:30A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
Published on: December 27, 2013
5.4K
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
683
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
683
Anticholinesterase Agents: Poisoning and Treatment
861
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
861
Antidotes
649
Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
649
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
982
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
982
Effects of Chemicals: Overview
1.3K
Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
1.3K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
454
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
454
